EACR-AACR-IACR 2024 Basic & Translational Research Conference: How to Bring Basic Science Discoveries to the Clinic

The EACR and AACR are proud to announce the 2024 edition of their joint Basic and Translational Research Conference, organised in conjunction with the IACR. The forum will highlight the latest cutting-edge advances in the understanding of the genomics, epigenetics, and molecular pathways involved in the development of pre-cancerous and cancerous lesions, and in cancer response to therapy. The scientific programme blends basic and translational research from preclinical models to patients. Topics include immunotherapy, cell-based therapies, novel/undruggable targets, drug combinations and resistance, the precancer genome, liquid biopsies, preclinical models, the tumour microenvironment, and epigenetics. The target audience is basic and translational scientists, experienced investigators and trainees at all levels with an interest in cancer development and treatment, and clinicians involved in the development of novel therapeutic approaches to treatment.

Topics: NK cell immunity, CAR T cells, solid tumours, PML nuclear bodies, AML response to therapies, synergistic cancer drug combinations, immune contexture, immunoscore, carcinogenesis, Clonal Hematopoiesis (prevention of hematologic malignancies), Fanconi anemia, stem cell attrition, genomic instability, neoadjuvant immune checkpoint blockade, cancer liquid biopsies, MYC inhibitor, preclinical models for translational research, stromal heterogeneity and spatial distribution, cell plasticity, disease mechanisms in cancer, Polycomb Epigenetic Regulators, cancer research, oncology